Xeris (Nasdaq: XERS) is often a development-oriented biopharmaceutical business committed to increasing clients’ lives by acquiring and commercializing differentiated and innovative items across A selection of therapies. Xeris has 3 commercially accessible items: Gvoke®, a Completely ready-to-use liquid glucagon for that remedy of severe hypogly